8 Ankylosing Spondylitis Clinical Trials in New Brunswick, NJ (2026)

Q: How do I join a clinical trial in New Brunswick?

Browse available studies, click one that interests you, and complete the free eligibility form. A study coordinator at the New Brunswick research site will contact you.

Recruiting Ankylosing Spondylitis Studies in New Brunswick

NCT07052942Recruiting

Individualizing Treatment for Asthma in Primary Care (Full Study)

While asthma therapy is becoming more individualized based on asthma phenotypes, more research is needed to tailor newer therapies to individuals. Inhaled corticosteroid (ICS) medications are the foun...

New Brunswick, NJPHASE43,200 participantsDARTNet Institute

View Study Details

NCT05581004Recruiting

A Study to Evaluate the Safety, Pharmacokinetics, and Activity of Enzelkitug as a Single Agent and in Combination With Checkpoint Inhibitor in Participants With Locally Advanced or Metastatic Solid Tumors

This is a first-in-human study to evaluate the safety, tolerability, pharmacokinetics (PK), and anti-tumor activity of enzelkitug when administered as a single agent and in combination with atezolizum...

New Brunswick, NJPHASE1450 participantsGenentech, Inc.

View Study Details

NCT07260916Recruiting

Minimally Invasive Neuroendoscopic Ultra-Early Targeted ICH Evacuation

MINUTE is a prospective, multi-center, randomized, controlled, blinded assessor, adaptive enrichment design, clinical trial. Eligible patients with spontaneous BGH ≥20 mL will be randomized 1:1 to eit...

New Brunswick, NJNA300 participantsIcahn School of Medicine at Mount Sinai

View Study Details

NCT07630974Recruiting

A Study of Ifinatamab Deruxtecan in Pediatric Participants With Relapsed or Refractory Solid Tumors (MK-9999-01D/LIGHTBEAM-U01)

Researchers are looking for new ways to treat children with relapsed or refractory solid tumors: * Relapsed means the cancer came back after treatment * Refractory means the cancer did not respond (g...

New Brunswick, NJPHASE1134 participantsMerck Sharp & Dohme LLC

View Study Details

NCT07080242Recruiting

Evaluating BL-M14D1 in Subjects With Locally Advanced or Metastatic Small Cell Lung Cancer and Neuroendocrine Tumors

The objective of this study is to evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of BL-M14D1 in Subjects with locally Advanced or Metastatic Small Cell Lung Cancer and Other Neuroen...

New Brunswick, NJPHASE1120 participantsSystImmune Inc.

View Study Details

NCT07165691Recruiting

TELEhealth Shared Decision-making COaching for Lung Cancer Screening in Primary Care (TELESCOPE) for Hispanics

Aim 1: Culturally adapt the TELESCOPE intervention for Hispanics. Using iterative qualitative feedback from a study-specific Community Advisory Board, focus groups, and interviews with community membe...

New Brunswick, NJNA91 participantsRutgers, The State University of New Jersey

View Study Details

NCT05332002Recruiting

sFOLFOXIRI in Advanced Gastroesophageal Cancer, (SAGE)

The primary objective is to determine the clinical efficacy of treatment regimen in terms of objective response rate (ORR). The secondary objectives is to determine the clinical efficacy of the study ...

New Brunswick, NJPHASE238 participantsRutgers, The State University of New Jersey

View Study Details

NCT05790668Recruiting

Motivational Refinements for Facilitating Reinforcement Schedule Thinning

Destructive behavior represents a comorbid condition of developmental disability for which risk increases with intellectual disability severity, communication deficits, and co-occurring autism spectru...

New Brunswick, NJNA30 participantsRutgers, The State University of New Jersey

View Study Details

About Ankylosing Spondylitis Clinical Trials in New Brunswick

Ankylosing spondylitis is a chronic inflammatory disease primarily affecting the spine and sacroiliac joints, causing pain, stiffness, and potentially spinal fusion. It typically begins in early adulthood. Treatment includes NSAIDs, biologics (TNF and IL-17 inhibitors), and physical therapy.

There are currently 8 ankylosing spondylitis clinical trials recruiting participants in New Brunswick, NJ. These studies are seeking a combined 4,363 participants. Research is being sponsored by DARTNet Institute, Genentech, Inc., Icahn School of Medicine at Mount Sinai and 3 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.

Ankylosing Spondylitis Clinical Trials in New Brunswick — FAQ

Are there ankylosing spondylitis clinical trials in New Brunswick?

Yes, there are 8 ankylosing spondylitis clinical trials currently recruiting in New Brunswick, NJ. Browse the studies on this page to find one that fits.

How do I join a clinical trial in New Brunswick?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the New Brunswick research site will contact you about next steps.

Are clinical trials in New Brunswick free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many New Brunswick studies also compensate for your time and travel.

What ankylosing spondylitis treatments are being tested?

The 8 active trials in New Brunswick are testing new therapies including novel drugs, biologics, and treatment approaches for ankylosing spondylitis.

Data updated July 18, 2026 from ClinicalTrials.gov